Gilead: Q2 Earnings Snapshot

sfgate2021-07-30

FOSTER CITY, Calif. (AP) _ Gilead Sciences Inc. (GILD) on Thursday reported second-quarter net income of $1.52 billion, after reporting a loss in the same period a year earlier.

On a per-share basis, the Foster City, California-based company said it had net income of $1.21. Earnings, adjusted for non-recurring costs, were $1.87 per share.

The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $1.76 per share.

The HIV and hepatitis C drugmaker posted revenue of $6.22 billion in the period, also topping Street forecasts. Six analysts surveyed by Zacks expected $6.15 billion.

Gilead expects full-year earnings in the range of $6.90 to $7.25 per share.

Gilead shares have climbed 20% since the beginning of the year, while the S&P's 500 index has increased 18%. In the final minutes of trading on Thursday, shares hit $69.81, a decrease of slightly more than 4% in the last 12 months.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • mseokt
    2021-07-30
    mseokt
    Yess ? 
  • Leehui1984
    2021-07-30
    Leehui1984
    Good
  • HappyWolf
    2021-07-30
    HappyWolf
    [Cool] [Cool] 
  • NatYong
    2021-07-30
    NatYong
    In the final minutes of trading on Thursday, shares hit $69.81, a decrease of slightly more than 4% in the last 12 months.
  • Haw75
    2021-07-30
    Haw75
    Like latest 
  • KaiQING
    2021-07-30
    KaiQING
    ,
Leave a comment
6